The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-03
DOI
10.1038/s41398-022-01987-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved symptoms following bumetanide treatment in children aged 3 to 6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial
- (2021) Yuan Dai et al. Science Bulletin
- Placing old wine into new bottles: successful repurposing of bumetanide for treatment of autism spectrum disorder
- (2021) Anthony G. Phillips Science Bulletin
- The Lancet Commission on the future of care and clinical research in autism
- (2021) Catherine Lord et al. LANCET
- Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
- (2020) Lingli Zhang et al. Translational Psychiatry
- Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase Two, Superiority Trial
- (2020) Jan J. Sprengers et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
- (2020) Zhiyu Wang et al. PeerJ
- Prenatal air pollution influences neurodevelopment and behavior in autism spectrum disorder by modulating mitochondrial physiology
- (2020) Richard E. Frye et al. MOLECULAR PSYCHIATRY
- Environmental regulation of the chloride transporter KCC2: switching inflammation off to switch the GABA on?
- (2020) Davide Pozzi et al. Translational Psychiatry
- Off-Label Use of Bumetanide for Brain Disorders: An Overview
- (2019) Shivani C. Kharod et al. Frontiers in Neuroscience
- Serum cytokine levels in children with spectrum autism disorder: Differences in pro- and anti-inflammatory balance
- (2019) Natalia Karolina Kordulewska et al. JOURNAL OF NEUROIMMUNOLOGY
- A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude
- (2019) Amene Saghazadeh et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis
- (2019) Amene Saghazadeh et al. CYTOKINE
- Maternal Immune Activation Delays Excitatory-to-Inhibitory Gamma-Aminobutyric Acid Switch in Offspring
- (2018) Irene Corradini et al. BIOLOGICAL PSYCHIATRY
- Bumetanide attenuates acute lung injury by suppressing macrophage activation
- (2018) Chin-Mao Hung et al. BIOCHEMICAL PHARMACOLOGY
- Autism spectrum disorder
- (2018) Catherine Lord et al. LANCET
- Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials
- (2018) B. Jordan James et al. ANNALS OF PHARMACOTHERAPY
- The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder
- (2017) Anne Masi et al. Neuroscience Bulletin
- Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress
- (2017) Die Hu et al. Scientific Reports
- Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder
- (2017) Anne Masi et al. Molecular Autism
- Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
- (2017) E Lemonnier et al. Translational Psychiatry
- Premature mortality in autism spectrum disorder
- (2016) Tatja Hirvikoski et al. BRITISH JOURNAL OF PSYCHIATRY
- The Role of the Immune System in Autism Spectrum Disorder
- (2016) Amory Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- Defining Precision Medicine Approaches to Autism Spectrum Disorders: Concepts and Challenges
- (2016) Eva Loth et al. Frontiers in Psychiatry
- A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism
- (2015) Lin Du et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set
- (2015) Malika Charrad et al. Journal of Statistical Software
- Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring
- (2014) R. Tyzio et al. SCIENCE
- Neonatal levels of cytokines and risk of autism spectrum disorders: An exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank
- (2012) Morsi W. Abdallah et al. JOURNAL OF NEUROIMMUNOLOGY
- The role of the innate immune system in psychiatric disorders
- (2012) Kenneth A. Jones et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- GABA system dysfunction in autism and related disorders: From synapse to symptoms
- (2012) Suzanne Coghlan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A randomised controlled trial of bumetanide in the treatment of autism in children
- (2012) E Lemonnier et al. Translational Psychiatry
- The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects
- (2010) Eric Lemonnier et al. ACTA PAEDIATRICA
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
- (2010) Paul Ashwood et al. BRAIN BEHAVIOR AND IMMUNITY
- Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
- (2010) Paul Ashwood et al. JOURNAL OF NEUROIMMUNOLOGY
- Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
- (2010) Hsiao-Tuan Chao et al. NATURE
- Elevated immune response in the brain of autistic patients
- (2009) Xiaohong Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle
- (2008) Jens Schmidt et al. BRAIN
- Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes
- (2008) P ASHWOOD et al. JOURNAL OF NEUROIMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation